Showing results (141-150 of 156) with videos related to
Sort By:
Pageof 16
Journal for Immunotherapy of Cancer|November 24, 2022
Nivolumab serum concentration in metastatic melanoma patients could be related to outcome and enhanced immune activity: a gene profiling retrospective analysisDomenico Mallardo, Diana Giannarelli, Maria Grazia Vitale, et al.Journal for Immunotherapy of Cancer|July 9, 2025
Gene-expression signature predicts autoimmune toxicity in metastatic melanomaDomenico Mallardo, Mario Fordellone, Michael Bailey, et al.Journal of Experimental & Clinical Cancer Research : CR|July 20, 2019
Large oncosomes overexpressing integrin alpha-V promote prostate cancer adhesion and invasion via AKT activationChiara Ciardiello, Alessandra Leone, Paola Lanuti, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2024
Intermittent or Continuous Panitumumab Plus Fluorouracil, Leucovorin, and Irinotecan for First-Line Treatment of RAS and BRAF Wild-Type Metastatic Colorectal Cancer: The IMPROVE TrialAntonio Avallone, Francesco Giuliani, Alfonso De Stefano, et al.JAMA Network Open|July 26, 2021
Effect of Bevacizumab in Combination With Standard Oxaliplatin-Based Regimens in Patients With Metastatic Colorectal Cancer: A Randomized Clinical TrialAntonio Avallone, Maria C Piccirillo, Guglielmo Nasti, et al.Journal of Cellular Physiology|April 27, 2007
The immunomodulatory protein SV-IV protects serum-deprived cells against apoptosis but not against G0/G1 arrest: possible implications for the survival of implanting embryoFrancesco Morelli, Gianfranco Peluso, Orsolina Petillo, et al.Journal of Experimental & Clinical Cancer Research : CR|December 20, 2025
miRquad: first-in-class dPCR multiplex TaqMan™ Advanced clinical research assay for microRNA detection in head and neck cancerMatteo Allegretti, David J Joun, Giulia Urbani, et al.Therapeutic Advances in Medical Oncology|August 28, 2020
Randomized phase II study of valproic acid in combination with bevacizumab and oxaliplatin/fluoropyrimidine regimens in patients with RAS-mutated metastatic colorectal cancer: the REVOLUTION study protocolAntonio Avallone, Maria Carmela Piccirillo, Elena Di Gennaro, et al.BMC Cancer|November 26, 2016
Phase II clinical study of valproic acid plus cisplatin and cetuximab in recurrent and/or metastatic squamous cell carcinoma of Head and Neck-V-CHANCE trialFrancesco Caponigro, Elena Di Gennaro, Franco Ionna, et al.The EMBO Journal|March 22, 2021
Golgi maturation-dependent glycoenzyme recycling controls glycosphingolipid biosynthesis and cell growth via GOLPH3Riccardo Rizzo, Domenico Russo, Kazuo Kurokawa, et al.Pageof 16